| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.13B | 76.71B | 59.20B | 51.89B | 49.86B | 34.62B |
| Gross Profit | 21.85B | 23.59B | 19.39B | 17.31B | 18.33B | 11.76B |
| EBITDA | 18.89B | 19.83B | 17.31B | 15.78B | 16.56B | 9.94B |
| Net Income | 9.41B | 9.30B | 9.45B | 7.70B | 7.74B | 3.30B |
Balance Sheet | ||||||
| Total Assets | 173.18B | 205.22B | 182.47B | 141.09B | 127.99B | 79.36B |
| Cash, Cash Equivalents and Short-Term Investments | 76.25B | 96.77B | 85.22B | 70.76B | 67.94B | 27.77B |
| Total Debt | 10.12B | 23.44B | 12.28B | 6.66B | 9.37B | 9.41B |
| Total Liabilities | 40.74B | 51.89B | 46.93B | 25.66B | 26.52B | 24.41B |
| Stockholders Equity | 69.10B | 80.22B | 68.56B | 56.26B | 47.12B | 28.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.43B | 4.24B | 8.53B | 10.00B | 337.57M |
| Operating Cash Flow | 0.00 | 14.84B | 13.14B | 13.86B | 15.32B | 9.34B |
| Investing Cash Flow | 0.00 | -13.48B | -6.61B | -8.92B | 31.69B | -13.02B |
| Financing Cash Flow | 0.00 | 8.56B | 1.94B | -4.84B | -491.96M | 5.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥74.62B | 15.26 | 12.96% | 1.36% | 18.44% | 26.68% | |
76 Outperform | ¥322.12B | 15.35 | 5.77% | 3.28% | 11.15% | -19.39% | |
71 Outperform | ¥468.23B | 22.63 | ― | 1.02% | 29.60% | 24.39% | |
69 Neutral | ¥108.38B | 9.50 | ― | 0.93% | 28.52% | 43.16% | |
69 Neutral | ¥575.52B | 13.81 | ― | 0.79% | 15.38% | -26.84% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | ¥121.89B | -7.98 | ― | 2.45% | 4.60% | -21.64% |